RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
More about Open Access at the CrickAuthors list
Nader Yatim Hélène Jusforgues-Saklani Susana Orozco Oliver Schulz Rosa Barreira da Silva Caetano Reis e Sousa Douglas R Green Andrew Oberst Matthew L AlbertAbstract
Dying cells initiate adaptive immunity by providing both antigens and inflammatory stimuli for dendritic cells, which in turn activate CD8(+) T cells through a process called antigen cross-priming. To define how different forms of programmed cell death influence immunity, we established models of necroptosis and apoptosis, in which dying cells are generated by receptor-interacting protein kinase-3 and caspase-8 dimerization, respectively. We found that the release of inflammatory mediators, such as damage-associated molecular patterns, by dying cells was not sufficient for CD8(+) T cell cross-priming. Instead, robust cross-priming required receptor-interacting protein kinase-1 (RIPK1) signaling and nuclear factor κB (NF-κB)-induced transcription within dying cells. Decoupling NF-κB signaling from necroptosis or inflammatory apoptosis reduced priming efficiency and tumor immunity. Our results reveal that coordinated inflammatory and cell death signaling pathways within dying cells orchestrate adaptive immunity.
Journal details
Journal Science
Volume 350
Issue number 6258
Pages 328-334
Available online
Publication date
Full text links
Publisher website (DOI) 10.1126/science.aad0395
Figshare View on figshare
Europe PubMed Central 26405229
Pubmed 26405229
Keywords
Related topics
Type of publication